References
- National Asthma Education and Prevention ProgramExpert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma 2007 Available at: http://www.nhlbi.nih.gov/guidelines/asthma/index.htm [Last accessed April 2008].
- MasoliMFabianDHoltSBeasleyRThe global burden of asthma: executive summary of the GINA Dissemination Committee reportAllergy20045946947815080825
- AccordiniSBugianiMArossaWPoor control increases the economic cost of asthma. A multicentre population-based studyInt Arch Allergy Immunol200614118919816899987
- BriggsAHBousquetJWallaceMVCost-effectiveness of asthma control: an economic appraisal of the GOAL studyAllergy20066153153616629780
- Food and Drug AdministrationUse of ozone-depleting substances; removal of essential-use designations; final ruleFed Regist2005701716817192
- HorneRCompliance, adherence, and concordance: implications for asthma treatmentChest200613065S72S16840369
- KrishnanJARiekertKAMcCoyJVCorticosteroid use after hospital discharge among high-risk adults with asthmaAm J Respir Crit Care Med20041701281128515374842
- MolimardMLe GrosVImpact of patient-related factors on asthma controlJ Asthma20084510911318350401
- SternLBermanJLumryWMedication compliance and disease exacerbation in patients with asthma: a retrospective study of managed care dataAnn Allergy Asthma Immunol20069740240817042149
- WilliamsLKPladevallMXiHRelationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthmaJ Allergy Clin Immunol20041141288129315577825
- GuestJFDavieAMRuizFJGreenerMJSwitching asthma patients to a once-daily inhaled steroid improves compliance and reduces healthcare costsPrim Care Respir J200514889816701704
- FriedmanHSYawnBPResource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroidsCurr Med Res Opin20072342743417288696
- ColiceGWuEQBirnbaumHHealthcare and workloss costs associated with patients with persistent asthma in a privately insured populationJ Occup Environ Med20064879480216902372
- BirnbaumHGIvanovaJIYuAPAsthma severity categorization using a claims-based algorithm or pulmonary function testingJ Asthma200946677219191141
- LaneSMolinaJPlusaTAn international observational prospective study to determine the cost of asthma exacerbations (COAX)Respir Med200610043445016099149
- KambleSBharmalMIncremental direct expenditure of treating asthma in the United StatesJ Asthma200946738019191142
- American Lung AssociationTrends in Asthma Morbidity and MortalityNew York, NYEpidemiology and Statistics Unit New York, NY
- BarnesNCThe properties of inhaled corticosteroids: similarities and differencesPrim Care Respir J20071614915417530144
- ClaxtonAJCramerJPierceCA systematic review of the associations between dose regimens and medication complianceClin Ther2001231296131011558866
- PriceDRobertsonABullenKImproved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label studyBMC Pulm Med10120051135
- BenderBGBenderSEPatient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnairesImmunol Allergy Clin North Am20052510713015579367
- EisenSAMillerDKWoodwardRSThe effect of prescribed daily dose frequency on patient medication complianceArch Intern Med1990150188118842102668
- HaynesRBYaoXDeganiAInterventions to enhance medication adherenceCochrane Database Syst Rev2005CD00001116235271
- Asmanex® Twisthaler® (mometasone furoate)Full Prescribing InformationMerck & Co Inc.Whitehouse Station, NJ, USA2008
- KarpelJPAn easy-to-use dry-powder inhalerAdv Ther20001728228611317831
- WardlawALariveePEllerJEfficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionateAnn Allergy Asthma Immunol200493495515281471